These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22371483)

  • 1. Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A).
    Wong PP; Miranda F; Chan KV; Berlato C; Hurst HC; Scibetta AG
    Mol Cell Biol; 2012 May; 32(9):1633-44. PubMed ID: 22371483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
    Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
    J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine demethylase 5B suppresses CC chemokine ligand 14 to promote progression of colorectal cancer through the Wnt/β-catenin pathway.
    Yan G; Li S; Yue M; Li C; Kang Z
    Life Sci; 2021 Jan; 264():118726. PubMed ID: 33160990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.
    Hayami S; Yoshimatsu M; Veerakumarasivam A; Unoki M; Iwai Y; Tsunoda T; Field HI; Kelly JD; Neal DE; Yamaue H; Ponder BA; Nakamura Y; Hamamoto R
    Mol Cancer; 2010 Mar; 9():59. PubMed ID: 20226085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer.
    Yeh IJ; Esakov E; Lathia JD; Miyagi M; Reizes O; Montano MM
    Sci Rep; 2019 Nov; 9(1):17663. PubMed ID: 31776402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis.
    Huang J; Jin S; Guo R; Wu W; Yang C; Qin Y; Chen Q; He X; Qu J; Yang Z
    RNA; 2024 Mar; 30(4):435-447. PubMed ID: 38296629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the Interaction of the Histone Demethylase KDM5B with Tricarboxylic Acid Cycle Intermediates.
    Tarhonskaya H; Nowak RP; Johansson C; Szykowska A; Tumber A; Hancock RL; Lang P; Flashman E; Oppermann U; Schofield CJ; Kawamura A
    J Mol Biol; 2017 Sep; 429(19):2895-2906. PubMed ID: 28827149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma.
    Gong J; Yan S; Yu H; Zhang W; Zhang D
    Med Sci Monit; 2018 Oct; 24():7586-7594. PubMed ID: 30353907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity.
    Jamshidi S; Catchpole S; Chen J; So CWE; Burchell J; Rahman KM; Taylor-Papadimitriou J
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34713299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer.
    Guan T; Zhang Y; Li S; Zhang W; Song Y; Li Y; He Y; Chen Y
    Eur J Med Chem; 2024 Jun; 272():116494. PubMed ID: 38749268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of human KDM5B guides histone demethylase inhibitor development.
    Johansson C; Velupillai S; Tumber A; Szykowska A; Hookway ES; Nowak RP; Strain-Damerell C; Gileadi C; Philpott M; Burgess-Brown N; Wu N; Kopec J; Nuzzi A; Steuber H; Egner U; Badock V; Munro S; LaThangue NB; Westaway S; Brown J; Athanasou N; Prinjha R; Brennan PE; Oppermann U
    Nat Chem Biol; 2016 Jul; 12(7):539-45. PubMed ID: 27214403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone demethylase KDM5B licenses macrophage-mediated inflammatory responses by repressing Nfkbia transcription.
    Zhang Y; Gao Y; Jiang Y; Ding Y; Chen H; Xiang Y; Zhan Z; Liu X
    Cell Death Differ; 2023 May; 30(5):1279-1292. PubMed ID: 36914768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling.
    Liu J; Liu Z; Li M; Tang W; Pratap UP; Luo Y; Altwegg KA; Li X; Zou Y; Zhu H; Sareddy GR; Viswanadhapalli S; Vadlamudi RK
    Mol Oncol; 2021 Apr; 15(4):1146-1161. PubMed ID: 33269540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis.
    Zhang B; Li J; Wang Y; Liu X; Yang X; Liao Z; Deng S; Deng Y; Zhou Z; Tian Y; Wei W; Meng J; Hu Y; Wan C; Zhang Z; Huang F; Wen L; Wu B; Sun Y; Li Y; Yang K
    Cell Death Differ; 2024 Mar; 31(3):309-321. PubMed ID: 38287116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular architecture of the Jumonji C family histone demethylase KDM5B.
    Dorosz J; Kristensen LH; Aduri NG; Mirza O; Lousen R; Bucciarelli S; Mehta V; Sellés-Baiget S; Solbak SMØ; Bach A; Mesa P; Hernandez PA; Montoya G; Nguyen TTTN; Rand KD; Boesen T; Gajhede M
    Sci Rep; 2019 Mar; 9(1):4019. PubMed ID: 30858420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine demethylase 5B (KDM5B): A key regulator of cancer drug resistance.
    Cao Y; Wu C; Ma L
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23587. PubMed ID: 38014925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas.
    Darvishi E; Slemmons K; Wan Z; Mitra S; Hou X; Parmentier JH; Eddie Loh YH; Helman LJ
    Neoplasia; 2020 Jul; 22(7):274-282. PubMed ID: 32464274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor TFAP2C regulates major programs required for murine fetal germ cell maintenance and haploinsufficiency predisposes to teratomas in male mice.
    Schemmer J; Araúzo-Bravo MJ; Haas N; Schäfer S; Weber SN; Becker A; Eckert D; Zimmer A; Nettersheim D; Schorle H
    PLoS One; 2013; 8(8):e71113. PubMed ID: 23967156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol-associated fibrosis in females is mediated by female-specific activation of lysine demethylases KDM5B and KDM5C.
    Schonfeld M; Averilla J; Gunewardena S; Weinman SA; Tikhanovich I
    Hepatol Commun; 2022 Aug; 6(8):2042-2057. PubMed ID: 35468265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and binding properties of a cameloid nanobody raised against KDM5B.
    Wiuf A; Kristensen LH; Kristensen O; Dorosz J; Jensen J; Gajhede M
    Acta Crystallogr F Struct Biol Commun; 2015 Oct; 71(Pt 10):1235-41. PubMed ID: 26457512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.